Pharma firms to thrive in the US market boosted by new products and drug demand
In Q1, the US business of the rated companies grew by a remarkable 26.6 per cent YoY
Stay updated with breaking news from Pharma Sector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In Q1, the US business of the rated companies grew by a remarkable 26.6 per cent YoY
US-based private equity firm Bain Capital is exploring a joint bid with Dr. Reddy’s Laboratories for the promoter stake
Transaction in line with our strategy of strengthening OTC and wellness portfolio, says firm
"As exports are not doing good for the last few months, there is a demand to extend it for about six months till March 2024. It is under consideration. We may extend it," the official said. These three sectors were late entrants into the scheme that aims to refund duties, taxes and levies at the central, state and local level that gets added to the cost of products meant for exports.
Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential.